liver cancer, lung cancer, cerebral aneurysm, thoracoabdominal aortic aneurysm, and arteriovenous malformation.
Conditions
Interventions
study group:Doctors diagnose patients and perform interventional procedures under artificial intelligence-assisted low-dose DSA/CB-CT
control group:Doctors diagnose patients and perform interventional procedures under clinically available DSA/CB-CT
Sponsors
Union hospital Tongji Medical College of Huazhong University of Science and Technology
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. 18-80 years old; 2. Patients who need DSA/CT-DSA examination due to various vascular diseases or malignant tumor history; 3. Patients or family members agree to join the clinical research and sign an informed consent form; 4. Each subject Participants must meet all inclusion criteria to be eligible to participate in the study.
Exclusion criteria
Exclusion criteria: 1. Patients who are allergic to contrast agents; 2. Patients with severe coagulation dysfunction or platelet count <50×109/L; 3. Patients with severe heart, lung, and renal dysfunction; 4. Patients who cannot cooperate well with diagnosis and treatment during the operation. Patients or patients who voluntarily withdraw from this study; 5. Any other reason why the researcher believes that the patient is not suitable to participate in this study; 6. All baseline subjects who meet any of the exclusion criteria will be excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Radiation dose;image quality; | — |
Secondary
| Measure | Time frame |
|---|---|
| diagnostic efficacy or surgical efficiency; | — |
Countries
china
Contacts
Public ContactZheng Chuansheng
Union hospital Tongji Medical College of Huazhong University of Science and Technology
Outcome results
None listed